Bisma Rauff

Bisma Rauff


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2020 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
BRBisma Rauff
Bisma Rauff
AMArif Malik
Arif Malik
YBYasir Ali Bhatti
Yasir Ali Bhatti
SCShafiq Ahmad Chudhary
Shafiq Ahmad Chudhary
IQIshtiaq Qadri
Ishtiaq Qadri
SRShafquat Rafiq
Shafquat Rafiq
Notch signalling pathway in development of cholangiocarcinoma

1 October 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
BRBisma Rauff
Bisma Rauff
AMArif Malik
Arif Malik
YBYasir A. Bhatti
Yasir A. Bhatti
SCShafiq A. Chudhary
Shafiq A. Chudhary
KFKaneez Fatima
Kaneez Fatima
IQIshtiaq Qadri
Ishtiaq Qadri
Cardiovascular diseases (CVD), primarily inflammatory cardiomyopathy, are characterized by the infiltration of inflammatory cells into the myocardium. It has a relatively high risk of deteriorating heart function and has heterogeneous etiologies. Inflammatory cardiomyopathy is mainly mediated by viral infections but can also be mediated by protozoa, fungal or bacterial infections. Besides that, there are a wide variety of drugs, toxic substances, and systemic immune-mediated diseases that result in the development of cardiovascular diseases (CVDs). Despite broad research, inflammatory cardiomyopathy has a poor prognosis. The roles of the pathogens, host genomic counterparts and environmental triggers in the progression of disease are still under consideration, including the role of some viruses as active inducers and others as bystanders. In this review article, we review the available evidence on the types, pathogenesis and treatment of myocarditis, inflammatory cardiomyopathy, and atherosclerosis with a particular focus on virus-associated cardiac diseases.

1 August 2023 in Future Virology
Verified
Journal Article
Closed access
BRBisma Rauff
Bisma Rauff
MRMehdi Ramezani-Moghadam
Mehdi Ramezani-Moghadam
ETEnoch Se Tay
Enoch Se Tay
JGJacob George
Jacob George
Mark William DouglasMark William Douglas
Mark William Douglas
Aim: To investigate the mechanism of liver fibrosis in chronic hepatitis C virus (HCV) infection we developed an in vitro model. Methods: Huh7 cells were transfected with HCV (JFH1 or Jc1) or sub-g... Plain language summary We developed a new laboratory model to study why people with hepatitis C develop liver damage. We plan to use this model to develop new treatments. We found that cells infect...

2 January 2026 in Journal of Tropical Pediatrics
Verified
Journal Article
Closed access
Munir Ahmad BhinderMunir Ahmad Bhinder
Munir Ahmad Bhinder
HSHaleema Sadia
Haleema Sadia
BRBisma Rauff
Bisma Rauff
ZHZawar Hussain
Zawar Hussain
MQMuhammad Qasim
Muhammad Qasim
MZMuhammad Yasir Zahoor
Muhammad Yasir Zahoor
Variants in the SLC26A4 gene are the most common cause of hereditary hearing loss in Pakistan, and the second most common cause worldwide. Advances in genetic diagnosis can make it more time-efficient, cost-effective, and accessible to clinicians and patients. The study aimed to screen 260 consanguineous Pakistani families with hereditary hearing loss for the DFNB4/PDS locus and to detect pathogenic SLC26A4 variants across different castes. We used homozygosity mapping to predict pathogenic variants and selected seven SLC26A4 exons for direct sequencing in 19 of the 23 DFNB4/PDS-linked families, based on haplotype comparison. Sequencing data were analyzed using Chromas software (Technelysium Pty. Ltd, version 1.45), and the detected variants were stratified by castes of the enrolled families. Four missense variations (c.269C>T, c.716T>A, c.1337A>G, and c.1667A>G) were identified in 16 families, as predicted by haplotype analysis, in exons 3, 6, 11, and 15 of SLC26A4. The Q446R (c.1337A>G) variant was identified in eight families, all belonging to the Arain caste of Pakistan. Caste data from a previous study of Pakistani patients similarly supported its potential role in caste-based genetic diagnosis. In PKDF497, six double heterozygotes for variants of GJB2 and SLC26A4 were detected without hearing loss. We present evidence supporting caste-based targeted variant screening for hereditary hearing loss. Following additional validation studies, caste-based targeted variant screening for common hereditary disorders could be implemented in developing countries, particularly in South Asia, to provide faster and more cost-effective molecular diagnosis compared to whole-genome or whole-exome sequencing.